Lithium bis(trifluoromethanesulphonyl)imide

We are Lithium bis(trifluoromethanesulphonyl)imide CAS:90076-65-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: Lithium bis(trifluoromethanesulphonyl)imide
CAS No: 90076-65-6
MF: C2F6LiNO4S2
MW: 287.08700
Density: 1,334 g/cm3
Boiling point: 190.5ºC at 760 mmHg
Melting point: 234-238 °C(lit.)
Flash point: 69ºC
UN Number: UN2923
UN Proper Shipping Name: CORROSIVE SOLID, TOXIC, N.O.S.
Transport hazard class: 6.1
Packing group: II
 
Specification
Appearance: White powder
Assay: ≥99.9%
PH: 6-9
Na: ≤10ppm
K: ≤5ppm
Fe: ≤2ppm
Al: ≤1ppm
Si: ≤5ppm
Mg: ≤1ppm
Zn: ≤1ppm
Ni: ≤1ppm
Cu: ≤1ppm
Ca: ≤5ppm
Pb: ≤1ppm
Cl: ≤15ppm
SO4: ≤20ppm
F: ≤20ppm
H2O: ≤100ppm
 
Application
It is an important fluorine-containing organic ionic compound, and it has important industrial application value in the fields of high-performance non-aqueous electrolyte materials for clean energy devices such as secondary lithium batteries, supercapacitors, and aluminum electrolytic capacitors, and new high-efficiency catalysts.
It can be used as a high-end antistatic agent for lithium battery organic electrolyte lithium salt, liquid crystal display (LCD, LED, OLED, etc.).
 
Package: 25kg/drum
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Lithium bis(trifluoromethanesulphonyl)imide


Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.4-Pyridinylboronic Acid CAS:1692-15-5 API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.3-Chloropropyl acetate The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.3-(2-Bromoacetyl)-5-chlorothiophene-2-sulfonamide CAS:160982-11-6 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.

Related Products
Product Name
1-CHLORO-6-IODOHEXANE View Details
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, (1S,3S,5S)- View Details
9-Bromo-1-nonanol View Details
BRADYKININ, ACETATE SALT manufacturer 2-(Trifluoromethoxy)nitrobenzene manufacturer 2,3,4,5,6-Pentafluorobenzoyl chloride manufacturer (Benzotriazol-1-yloxy)dipiperidinocarbenium hexafluorophosphate manufacturer Bis(2-dimethylaminoethyl) ether manufacturer